Association between cell-derived microparticles and adverse events in patients with nonpulsatile left ventricular assist devices

Journal of Heart and Lung Transplantation

Volumn 33, Issue 5, 2014, Pages 470-477

  Nascimbene, Angelo ^a   Hernandez, Ruben ^a   George, Joggy K ^a   Parker, Anita ^a   Bergeron, Angela L ^b   Pradhan, Subhashree ^b   Vijayan, K Vinod ^b   Civitello, Andrew ^a   Simpson, Leo ^a   Nawrot, Maria ^c   Lee, Vei Vei ^a   Mallidi, Hari R ^a   Delgado, Reynolds M ^a   Dong, Jing Fei ^c,d   Frazier, O H ^a  

^a TEXAS HEART INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c PUGET SOUND BLOOD CENTER   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

cell derived microparticles; phosphatidylserine; ventricular assist device

Indexed keywords

PHOSPHATIDYLSERINE;

ARTERY THROMBOSIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART VENTRICLE TACHYCARDIA; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MEDICAL DEVICE COMPLICATION; MEMBRANE MICROPARTICLE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; RISK FACTOR; TIME;

CELL-DERIVED MICROPARTICLES; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; PILOT PROJECTS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84898808086     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.01.004     Document Type: Article

References (29)

1. R. John, F. Kamdar, and K. Liao et al. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device J Thorac Cardiovasc Surg 136 2008 1318 1323
2. J. Klovaite, F. Gustafsson, S.A. Mortensen, K. Sander, and L.B. Nielsen Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II) J Am Coll Cardiol 53 2009 2162 2167
3. G. Interlandi, M. Ling, A.Y. Tu, D.W. Chung, and W.E. Thomas Structural basis of type 2A von Willebrand disease investigated by molecular dynamics simulations and experiments PLoS One 7 2012 e45207
4. D.R. Stern, J. Kazam, and P. Edwards et al. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD J Card Surg 25 2010 352 356
5. Letsou GV, Shah N, Gregoric ID, Myers TJ, Delgado R, Frazier OH. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant 2005;24:105-109.
6. S. Crow, R. John, and A. Boyle et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices J Thorac Cardiovasc Surg 137 2009 208 215
7. Z.T. Demirozu, R. Radovancevic, and L.F. Hochman et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device J Heart Lung Transplant 30 2011 849 853
8. T.S. Kato, T. Ota, and P.C. Schulze et al. Asymmetric pattern of cerebrovascular lesions in patients after left ventricular assist device implantation Stroke 43 2012 872 874
9. M.S. Slaughter, J.G. Rogers, and C.A. Milano et al. Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
10. H. Tsukui, A. Abla, and J.J. Teuteberg et al. Cerebrovascular accidents in patients with a ventricular assist device J Thorac Cardiovasc Surg 134 2007 114 123
11. S. Nomura, N.N. Tandon, T. Nakamura, J. Cone, S. Fukuhara, and J. Kambayashi High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells Atherosclerosis 158 2001 277 287
12. D. Bluestein, S. Einav, and M.J. Slepian Device thrombogenicity emulation: a novel methodology for optimizing the thromboresistance of cardiovascular devices J Biomech 46 2013 338 344
13. D. Bluestein, L. Niu, R.T. Schoephoerster, and M.K. Dewanjee Fluid mechanics of arterial stenosis: relationship to the development of mural thrombus Ann Biomed Eng 25 1997 344 356
14. J. Apel, R. Paul, S. Klaus, T. Siess, and H. Reul Assessment of hemolysis related quantities in a microaxial blood pump by computational fluid dynamics Artif Organs 25 2001 341 347
15. P. Diehl, F. Nagy, and V. Sossong et al. Increased levels of circulating microparticles in patients with severe aortic valve stenosis Thromb Haemost 99 2008 711 719
16. E.I. Sinauridze, D.A. Kireev, and N.Y. Popenko et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets Thromb Haemost 97 2007 425 434
17. Z. Mallat, B. Hugel, J. Ohan, G. Leseche, J.M. Freyssinet, and A. Tedgui Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity Circulation 99 1999 348 353
18. N. Amabile, C. Guignabert, D. Montani, Y. Yeghiazarians, C.M. Boulanger, and M. Humbert Cellular microparticles in the pathogenesis of pulmonary hypertension Eur Respir J 42 2013 272 279
19. D. Burger, D.G. Kwart, and A.C. Montezano et al. Microparticles induce cell cycle arrest through redox-sensitive processes in endothelial cells: implications in vascular senescence J Am Heart Assoc 1 2012 e001842
20. Y. Hayon, O. Dashevsky, E. Shai, A. Brill, D. Varon, and R.R. Leker Platelet microparticles induce angiogenesis and neurogenesis after cerebral ischemia Curr Neurovasc Res 9 2012 185 192
21. M.H. Gambim, O. do Carmo Ade, L. Marti, S. Verissimo-Filho, L.R. Lopes, and M. Janiszewski Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation: experimental evidence for a novel mechanism of septic vascular dysfunction Crit Care 11 2007 R107
22. P. Kang, B. Shen, J. Yang, and F. Pei Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head Thromb Res 123 2008 367 373
23. D.A. Manly, J. Wang, and S.L. Glover et al. Increased microparticle tissue factor activity in cancer patients with venous thromboembolism Thromb Res 125 2010 511 512
24. P. Diehl, M. Aleker, and T. Helbing et al. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation Interact Cardiovasc Thorac Surg 11 2010 133 137
25. L.H. Lund, J. Matthews, and K. Aaronson Patient selection for left ventricular assist devices Eur J Heart Fail 12 2010 434 443
26. J. Saunders, V. Nambi, and K.T. Kimball et al. Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients J Vasc Surg 53 2011 668 675
27. S. Guthikonda, C.L. Alviar, and M. Vaduganathan et al. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease J Am Coll Cardiol 52 2008 743 749
28. M.D. Shah, A.L. Bergeron, J.F. Dong, and J.A. Lopez Flow cytometric measurement of microparticles: pitfalls and protocol modifications Platelets 19 2008 365 372
29. V. Nambi, K.T. Kimball, and P.F. Bray et al. Differences in responses of platelets to fluid shear stress in patients with peripheral artery disease (PAD) and coronary artery disease (CAD) Platelets 20 2009 199 205